PP01.01: Multi-site profiling of small cell lung cancer and assessment of tumor heterogeneity through rapid research autopsy

PP01.02: AUTX-703, a novel and potent KAT2A and KAT2B proteint degrader, induces profound and persistent cell state differentiation and inhibits growth in SCLC Model Systems

PP01.04: REST represses neuroendocrine transcriptional programs and enables antitumor immunity in SCLC

PP01.05: Integrative single-cell tracking of genome evolution and tumor cell plasticity in Small Cell Lung Cancer (SCLC)

PP01.07: Identification of Synthetic Lethal Vulnerabilities Between TRIM28 and NOTCH2 in Small Cell Lung Cancer Through CRISPR/Cas9 Screening

PP01.08: FBXO11 mediates PARP inhibitor resistance in small-cell lung cancer

PP01.09: Non-Invasive Genomic and Transcriptomic Characterization of Small Cell Lung Cancer Using Circulating Tumor DNA

PP01.10 ASCL1 and NEUROD1 are Highly Specific Markers of Lung vs Digestive Carcinoids/Neuroendocrine Tumors

PP01.11: Human Pluripotent Stem Cell-based Approach to Decode Small Cell Lung Cancer Metastasis

PP01.12: Spatial profiling of the small cell lung carcinoma (SCLC) tumor-immune microenvironment (TIME)

PP01.13: Auto-antibodies identify neoepitopes of carbonic anhydrase-9 in SCLC

PP01.14: Combination surface targeting strategies in relapsed small cell lung cancer (SCLC) to overcome intratumoral heterogeneity associated with treatment resistance

PP01.15: Antitumor activities of HER2- and TROP2-directed antibody drug conjugates in recalcitrant pulmonary high-grade neuroendocrine carcinomas

PP01.16: The Polycomb Protein EED Constrains the SCLC Neuroendocrine Phenotype and Drives Lung Cancer Histological Transformation

PP01.17: Reconstructing small cell lung cancer evolution using deep whole genome sequencing of circulating tumor DNA

PP01.18: Genome-Wide CRISPR/Cas9 Screens Utilizing an Endogenous Reporter for ASCL1 Abundance Identifies Mechanisms of ASCL1 Protein Stability

PP01.19: Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer

PP01.21: MYC-Driven Histological Transformation Contributes to RB1-Proficient Small Cell Lung Cancer

PP01.23: Modeling the dynamics of tumor development and immune evasion in small cell lung cancer

PP01.24: Integrating chromatin profiling with gene expression to construct gene regulatory networks in small-cell lung cancer